81 – 90 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
- Contribution to journal › Article
-
Mark
Signaling by the Platelet-Derived Growth Factor Receptor Family
(2011) p.117-124
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Signaling by the Platelet-Derived Growth Factor Receptor Family
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML
- Contribution to journal › Article
-
Mark
Signaling by the Platelet-Derived Growth Factor Receptor Family
(2009) p.427-434
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Oncogenic flt3 receptors display different specificity and kinetics of autophosphorylation.
- Contribution to journal › Article
-
Mark
A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
- Contribution to journal › Article
-
Mark
Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.
- Contribution to journal › Scientific review
-
Mark
The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
- Contribution to journal › Article
-
Mark
The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.
- Contribution to journal › Article
